The Effect of Immune responses In Pathogenesis of Hepatitis B Virus Patients

Authors

  • Jabbar afat alwan AL-Qadysia University Author
  • Ali Anok Njum AL-Qadysia University Author

DOI:

https://doi.org/10.61841/rgxzdm40

Keywords:

CD79, CD45-R, Hepatitis B, HBV

Abstract

Study attempts to estimate immune molecules CD45- R & CD79 and cytokines TNF-α and IL-6 in patients infected with HBV

A total of (100) seropositive patients for HBV were screened for this study .Patients attended general lab, because of abdominal pain , jaundice and loss of appetite and other liver complaint, any serum samples expressed positive for anti-HBV antibodies directly choose to show level of TNF-α & IL-6 in serum of patient and show expression of CD45-R and CD79. Results showed that serum samples were analyzed for IL-6 & TNF-α by ELISA , showed highly significant increases (p<0.05) in serum level of HBV patients as compared with healthy control groups , acute HBV revealed high as well as , increases in serum level of TNF-α significantly(p<0.05) ,while chronic liver disease patients express high increase in serum level of IL-6 significantly(p<0.05).Activated markers study revealed high expression of CD79 & CD45-R in HBV patients as compared with healthy normal groups

Downloads

Download data is not yet available.

References

1- Hu, J., & Seeger, C. (2015). Hepadnavirus genome replication and 2-persistence. Cold Spring Harbor perspectives in medicine, 5(7), a021386.

2- Hussein, N. R., S. M. Haj, L. A. Almizori and A. A. Taha (2017). "The prevalence of hepatitis B and C viruses among blood donors attending blood bank in Duhok, Kurdistan region, Iraq." International Journal of Infection 4(1).

3- Hutin, Y., S. Desai and M. Bulterys (2018). "Preventing hepatitis B virus infection: milestones and targets." Bulletin of the World Health Organization 96(7): 443-443A.

4- İnan, N., & Tabak, F. (2015). Hepatitis B virus: Biology and life cycle.Viral Hepatitis Journal 21(1):1- 7.

5- Iqbal, K., Klevens, R. M., Kainer, M. A., Baumgartner, J., Gerard, K., Poissant, T., Khudyakov, Y. (2015). Epidemiology of acute hepatitis B in the united states from population-based surveillance, 2006–2011. Clinical infectious diseases, 61(4), 584-592.

6- Ismail, S. A., D. F. Cuadros and L. Benova (2017). "Hepatitis B in Egypt: a cross‐sectional analysis of prevalence and risk factors for active infection from a nationwide survey." Liver international 37(12): 1814-1822.

7- Jia, W., Qi, X., Ji, Y.-Y., Xun, Y.-H., Wang, H., Zhang, W.-H., . . . Mao, R.-C. (2015). Low serum

Hepatitis B surface antigen level predicts compensated cirrhosis caused by chronic Hepatitis B in HBeAg positive patients in east china. Hepatitis monthly, 15(8).

8- Kania, D., Ottomani, L., Meda, N., Peries, M., Dujols, P., Bolloré, K., Van de Perre, P. (2014). Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitation. Journal of virological methods, 201, 24-30.

9- Keane, E., Funk, A., & Shimakawa, Y. (2016). Systematic review with meta‐analysis: the risk of mother‐ to‐child transmission of hepatitis B virus infection in sub‐Saharan Africa. Alimentary pharmacology & therapeutics, 44(10), 1005-1017. Komatsu, H., Inui, A., & Fujisawa, T. (2016). The Role of Body Fluids in the Horizontal Transmission of Hepatitis B virus via Household/Close Contact. EMJ, 1(1), 68-75.

10- Kramvis, A. (2016). The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Reviews in medical virology, 26(4), 285-303.

11- Kühnert D, Wu CH, Drummond AJ (2011). "Phylogenetic and epidemic modeling of rapidly evolving infectious diseases". Infection, Genetics and Evolution. 11 (8): 1825–41.

12- Kurbanov, F., Tanaka, Y., & Mizokami, M. (2010). Geographical and genetic diversity of the human hepatitis B virus. Hepatology Research, 40(1), 14-30.

13- Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L., Papatheodoridis, G., Tacke, F. (2017). Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of hepatology, 67(2), 370-398.

14- Lavanchy, D., & Kane, M. (2016). Global epidemiology of hepatitis B virus infection Hepatitis B Virus in Human Diseases (187-203): Springer.

16- Le Viet, N. T. N. L., P. X. Ty, B. Björkvoll, H. Hoel, T. Gutteberg, A. Husebekk, S. Larsen, E. Skjerve and H. Husum (2012). "Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam." The Indian journal of medical research 136(1): 74.

18 Levrero, M., & Zucman-Rossi, J. (2016). Mechanisms of HBVinduced hepatocellular carcinoma.

Journal of hepatology, 64(1), S84- S101.

19- Li, X., Zhao, J., Yuan, Q., & Xia, N. (2017). Detection of HBV covalently closed circular DNA. Viruses, 9(6), 139.

20- Liu B.et al. . (2014) Combining evolutionary information extractedfrom frequency profiles with sequence-based kernels for proteinremote homology detection. Bioinformatics , 30, 472–479.

21- Liu, C.-J., & Kao, J.-H. (2013). Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Paper presented at the Seminars in liver disease.33(2):97-102.

22- Liu, Z., Dai, X., Wang, T., Zhang, C., Zhang, W., Zhang, W., . . . Liu, Y. (2017). Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of livercancer stem cells. Cancer letters, 400, 149-160.

23- Lok, A., & McMahon, B. (2014). Chronic hepatitis B: update 2009. Hepatology. American Association for the Study of Liver Diseases website.

24- Lucifora, J., & Protzer, U. (2016). Attacking hepatitis B virus cccDNA–The holy grail to hepatitis B cure. Journal of hepatology, 64(1), S41-S48.

25- Maini, M. K., & Gehring, A. J. (2016). The role of innate immunity in the immunopathology and treatment of HBV infection. Journal of hepatology, 64(1), S60-S70.

26- Matsuura, K., Tanaka, Y., Hige, S., Yamada, G., Murawaki, Y., Komatsu, M., Izumi, N. (2009). Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. Journal of clinical microbiology, 47(5), 1476-1483.

27- Yip W-K, Cheng AS-L, Zhu R, Lung RW-M, Tsang DP-F, Lau SS-K, et al.( 2011) . Carboxylterminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS One.;6:e22888.

28- Zekri, A.-R. N., M. M. Hafez, N. I. Mohamed, Z. K. Hassan, M. H. El-Sayed, M. M. Khaled and T. Mansour (2007). "Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection." Virology journal 4(1): 74.

29 Zhang, Q., & Cao, G. (2011). Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis. Hepatitis monthly, 11(2), 86.

30- Zoulim, F., Testoni, B., & Lebossé, F. (2013). Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studies. Clinical Gastroenterology and Hepatology, 11(8), 1011-1013.

Downloads

Published

30.06.2020

How to Cite

alwan, J. afat, & Njum, A. A. (2020). The Effect of Immune responses In Pathogenesis of Hepatitis B Virus Patients. International Journal of Psychosocial Rehabilitation, 24(6), 17655-17663. https://doi.org/10.61841/rgxzdm40